Best practices for the management of ...
Document type :
Article dans une revue scientifique: Article de synthèse/Review paper
DOI :
PMID :
Permalink :
Title :
Best practices for the management of local-regional recurrent chordoma: a position paper by the chordoma global consensus group
Author(s) :
Gronchi, A. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Fossati, P. [Auteur]
European Institute of Oncology [Milan] [ESMO]
Akiyama, T. [Auteur]
Saitama University
Alapetite, C. [Auteur]
Institut Curie [Paris]
Baumann, M. [Auteur]
University of Dresden Medical School
Blay, Jean-Yves [Auteur]
Centre Léon Bérard [Lyon]
Bolle, S. [Auteur]
Institut Gustave Roussy [IGR]
Boriani, S. [Auteur]
Bruzzi, P. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Capanna, R. [Auteur]
University of Pisa [Italy] = Università di Pisa [Italia] = Université de Pise [Italie] [UniPi]
Caraceni, A. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Casadei, R. [Auteur]
Colia, V. [Auteur]
Debus, J. [Auteur]
University Medical Center Heidelberg
Delaney, T. [Auteur]
Massachusetts General Hospital [Boston]
Desai, A. [Auteur]
Queen Elizabeth Hospital
Dileo, P. [Auteur]
University College London Hospitals [UCLH]
Dijkstra, S. [Auteur]
Universiteit Leiden = Leiden University
Doglietto, F. [Auteur]
Flanagan, A. [Auteur]
Cancer Research UK London Research Institute
Froelich, S. [Auteur]
Hôpital Lariboisière
Gardner, P A. [Auteur]
University of Pittsburgh School of Medicine
Gelderblom, Hans [Auteur]
Universiteit Leiden = Leiden University
Gokaslan, Z L. [Auteur]
Providence University
Haas, R. [Auteur]
Netherlands Cancer Institute [NKI]
Heery, C. [Auteur]
National Cancer Institute [Bethesda] [NCI-NIH]
Hindi, N. [Auteur]
Hospital Universitario Virgen del Rocío [Sevilla]
Hohenberger, P. [Auteur]
University of Heidelberg, Medical Faculty
Hornicek, F. [Auteur]
Harvard Medical School [Boston] [HMS]
Imai, R. [Auteur]
Chiba University Hospital
Jeys, L. [Auteur]
Queens Elizabeth Hospital [Birmingham]
Jones, R L. [Auteur]
Royal Marsden NHS Foundation Trust
Kasper, Bernd [Auteur]
University of Heidelberg, Medical Faculty
Kawai, A. [Auteur]
National Cancer Center Research Institute [Tokyo]
Krengli, M. [Auteur]
Università del Piemonte Orientale - Dipartimento DISIT Italy
Leithner, A. [Auteur]
Logowska, I. [Auteur]
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology [MCMCC]
Martin Broto, J. [Auteur]
Hospital Universitario Virgen del Rocío [Sevilla]
Mazzatenta, D. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Morosi, C. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Nicolai, P. [Auteur]
Norum, O J. [Auteur]
Patel, S. [Auteur]
MD Anderson Cancer Center [Houston]
Penel, Nicolas [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Picci, P. [Auteur]
Pilotti, S. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Radaelli, S. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Ricchini, F. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Rutkowski, P. [Auteur]
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology [MCMCC]
Scheipl, S. [Auteur]
University Hospital Graz
Sen, C. [Auteur]
New York University Langone Medical Center [NYU Langone Medical Center]
Tamborini, E. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Thornton, K A. [Auteur]
Harvard Medical School [Boston] [HMS]
Timmermann, B. [Auteur]
University of Duisbourg-Essen
Torri, V. [Auteur]
Tunn, P U. [Auteur]
Helios Klinikum [Erfurt]
Uhl, M. [Auteur]
University of Heidelberg, Medical Faculty
Yamada, Y. [Auteur]
Memorial Sloane Kettering Cancer Center [New York]
Weber, D C. [Auteur]
Paul Scherrer Institut [PSI]
Vanel, D. [Auteur]
Varga, P P. [Auteur]
Vleggeert-Lankamp, C La [Auteur]
Leiden University Medical Center [LUMC]
Casali, Paolo [Auteur]
Sommer, J. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Fossati, P. [Auteur]
European Institute of Oncology [Milan] [ESMO]
Akiyama, T. [Auteur]
Saitama University
Alapetite, C. [Auteur]
Institut Curie [Paris]
Baumann, M. [Auteur]
University of Dresden Medical School
Blay, Jean-Yves [Auteur]
Centre Léon Bérard [Lyon]
Bolle, S. [Auteur]
Institut Gustave Roussy [IGR]
Boriani, S. [Auteur]
Bruzzi, P. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Capanna, R. [Auteur]
University of Pisa [Italy] = Università di Pisa [Italia] = Université de Pise [Italie] [UniPi]
Caraceni, A. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Casadei, R. [Auteur]
Colia, V. [Auteur]
Debus, J. [Auteur]
University Medical Center Heidelberg
Delaney, T. [Auteur]
Massachusetts General Hospital [Boston]
Desai, A. [Auteur]
Queen Elizabeth Hospital
Dileo, P. [Auteur]
University College London Hospitals [UCLH]
Dijkstra, S. [Auteur]
Universiteit Leiden = Leiden University
Doglietto, F. [Auteur]
Flanagan, A. [Auteur]
Cancer Research UK London Research Institute
Froelich, S. [Auteur]
Hôpital Lariboisière
Gardner, P A. [Auteur]
University of Pittsburgh School of Medicine
Gelderblom, Hans [Auteur]
Universiteit Leiden = Leiden University
Gokaslan, Z L. [Auteur]
Providence University
Haas, R. [Auteur]
Netherlands Cancer Institute [NKI]
Heery, C. [Auteur]
National Cancer Institute [Bethesda] [NCI-NIH]
Hindi, N. [Auteur]
Hospital Universitario Virgen del Rocío [Sevilla]
Hohenberger, P. [Auteur]
University of Heidelberg, Medical Faculty
Hornicek, F. [Auteur]
Harvard Medical School [Boston] [HMS]
Imai, R. [Auteur]
Chiba University Hospital
Jeys, L. [Auteur]
Queens Elizabeth Hospital [Birmingham]
Jones, R L. [Auteur]
Royal Marsden NHS Foundation Trust
Kasper, Bernd [Auteur]
University of Heidelberg, Medical Faculty
Kawai, A. [Auteur]
National Cancer Center Research Institute [Tokyo]
Krengli, M. [Auteur]
Università del Piemonte Orientale - Dipartimento DISIT Italy
Leithner, A. [Auteur]
Logowska, I. [Auteur]
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology [MCMCC]
Martin Broto, J. [Auteur]
Hospital Universitario Virgen del Rocío [Sevilla]
Mazzatenta, D. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Morosi, C. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Nicolai, P. [Auteur]
Norum, O J. [Auteur]
Patel, S. [Auteur]
MD Anderson Cancer Center [Houston]
Penel, Nicolas [Auteur]

METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Picci, P. [Auteur]
Pilotti, S. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Radaelli, S. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Ricchini, F. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Rutkowski, P. [Auteur]
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology [MCMCC]
Scheipl, S. [Auteur]
University Hospital Graz
Sen, C. [Auteur]
New York University Langone Medical Center [NYU Langone Medical Center]
Tamborini, E. [Auteur]
Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
Thornton, K A. [Auteur]
Harvard Medical School [Boston] [HMS]
Timmermann, B. [Auteur]
University of Duisbourg-Essen
Torri, V. [Auteur]
Tunn, P U. [Auteur]
Helios Klinikum [Erfurt]
Uhl, M. [Auteur]
University of Heidelberg, Medical Faculty
Yamada, Y. [Auteur]
Memorial Sloane Kettering Cancer Center [New York]
Weber, D C. [Auteur]
Paul Scherrer Institut [PSI]
Vanel, D. [Auteur]
Varga, P P. [Auteur]
Vleggeert-Lankamp, C La [Auteur]
Leiden University Medical Center [LUMC]
Casali, Paolo [Auteur]
Sommer, J. [Auteur]
Journal title :
Annals of oncology . official journal of the European Society for Medical Oncology
Abbreviated title :
Ann. Oncol.
Volume number :
28
Pages :
1230-1242
Publication date :
2017-06-01
ISSN :
0923-7534
English keyword(s) :
chemotherapy
chordoma
sarcoma
relapse
radiotherapy
surgery
Mesh:Practice Guidelines as Topic*
Mesh:Neoplasm Recurrence
Mesh:Local
Mesh:Chordoma/therapy*
Mesh:Humans
chordoma
sarcoma
relapse
radiotherapy
surgery
Mesh:Practice Guidelines as Topic*
Mesh:Neoplasm Recurrence
Mesh:Local
Mesh:Chordoma/therapy*
Mesh:Humans
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and ...
Show more >Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evidence-based best practices for the optimal approach to chordoma. In January 2015, the first recommendations of this group were published, covering the management of primary and metastatic chordomas. Additional evidence and further discussion were needed to develop recommendations about the management of local-regional failures. Thus, ESMO and CF convened a second consensus group meeting in November 2015 to address the treatment of locally relapsed chordoma. This meeting involved over 60 specialists from Europe, the United States and Japan with expertise in treatment of patients with chordoma. The consensus achieved during that meeting is the subject of the present publication and complements the recommendations of the first position paper.Show less >
Show more >Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evidence-based best practices for the optimal approach to chordoma. In January 2015, the first recommendations of this group were published, covering the management of primary and metastatic chordomas. Additional evidence and further discussion were needed to develop recommendations about the management of local-regional failures. Thus, ESMO and CF convened a second consensus group meeting in November 2015 to address the treatment of locally relapsed chordoma. This meeting involved over 60 specialists from Europe, the United States and Japan with expertise in treatment of patients with chordoma. The consensus achieved during that meeting is the subject of the present publication and complements the recommendations of the first position paper.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
Université de Lille
Université de Lille
Submission date :
2019-12-09T18:16:43Z
2020-05-28T09:18:15Z
2020-05-28T09:18:15Z
Files
- PIIS0923753419324147.pdf
- Version éditeur
- Open access
- Access the document
Except where otherwise noted, this item's license is described as Attribution-NonCommercial 3.0 United States